Scope
This guideline outlines the initial management of acute alcohol or benzodiazepine withdrawal for those deployed on military operations. It is outside of the scope of this guideline to provide direction for all situations, and in particular this relates to the availability of medications within a unit/platform/facility on Operations. Pragmatism may be required by clinicians regarding what medication they have available to them, and reach back support from a mental health professional should be considered early in the treatment pathway.
Initial Assessment & Management
All personnel have the potential to display behaviour out-of-character, act erratically, or place themselves or others at risk of harm. This potential is increased on operations and should particularly be considered in psychiatric patients/ those experiencing acute symptoms of mental ill-health. Assess risk to you, those around you, and the patient ensuring an environment which is calm and without easy access to potential weapons (i.e. sharps). Routine MTF sanitisation would usually include removal of a patient’s weapon system. This should be checked, and consideration given to other potential weapons and the need for search of the patient to ensure safety.
ACUTE ALCOHOL WITHDRAWAL
Assessment and identification
Early identification and assessment is essential to ensure appropriate management and prevent chronic sequalae for the patient. Usual symptoms, and their timing of onset, are detailed in Table 1, with more severe symptoms and their management covered later in this guidance.
In addition to a comprehensive mental health assessment (CGO: Mental health assessment and initial interventions), patients will benefit from a more detailed alcohol history, which is shown below in accordion content. This may not be appropriate on operations due to time and privacy constraints, however, if possible, it provides very useful information for treatment and recovery (both acutely and in the longer term).
Physical health assessment is integral to the care of the patient. Regular (minimum every 4 hours) physical observations should be conducted. In addition, the physical signs of alcohol withdrawal should be scored every 4 hours using the CIWA-Ar scale, shown below. This scale indicates the severity of alcohol withdrawal and therefore guides the acute treatment.
Table 1: Mild symptoms of alcohol withdrawal
|
Symptoms
|
Usual timing of onset after the last drink
|
Other information
|
|
Agitation/anxiety/irritability
Tremor of hands, tongue, eyelids
Sweating
Nausea/vomiting/diarrhoea
Fever
Tachycardia
Systolic hypertension
General malaise
|
Onset at 3–12 hours
Peak at 24–48 hours
Duration up to 14 days
|
Symptoms are non-specific
Absence does not exclude withdrawal
May commence before blood alcohol levels reach zero
|
Initial management and escalation
Significant supplies of benzodiazepines and thiamine are required to treat alcohol withdrawal. Benzodiazepines provide symptomatic relief from symptoms and aim to prevent seizures (and other complications), whilst Thiamine aims to prevent permanent neurological damage (Korsakoff syndrome). Therefore, early aeromed evacuation (or transfer to a Role 3/4 facility) is usually required to avoid complications and manage potentially life-threatening deterioration. If the operational situation does not allow for aeromed evacuation, prioritise reach back mental health professional support.
Benzodiazepine and thiamine prescribing regimens are detailed within accordion content.
Management of severe symptoms
Generalised seizures. Severe alcohol withdrawal can lead to generalised seizures, which typically occur 12 to 18 hours after the last drink. Notably, these seizures may begin even before blood alcohol levels have completely reached zero. If this occurs, immediate stabilisation (using an ABC resuscitation approach) should be used. Evidence demonstrates that long-acting benzodiazepines preparations such as diazepam, significantly reduced seizures.
Delirium tremens (DT), a severe complication of alcohol withdrawal, typically manifests 3 to 4 days (72–96 hours) after the last drink and develops in 3–5% of those admitted to the hospital for alcohol withdrawal.
Symptoms include:
- clouding of consciousness or confusion,
- vivid visual and tactile hallucinations,
- marked tremor
- autonomic hyperactivity (such as tachycardia, hypertension, sweating, and fever).
- Other features may include paranoid delusions, agitation, and insomnia, with prodromal symptoms like night-time insomnia, restlessness, fear, and confusion.
Risk factors for DT include severe alcohol dependence, self-detoxification without medical input, multiple prior admissions for alcohol withdrawal, concurrent medical illness, a history of DT or alcohol withdrawal seizures, low potassium or magnesium levels, thiamine deficiency, and inadequately treated withdrawal.
DT is a medical emergency, with a mortality rate of 10–20% if untreated. Prompt recognition is crucial, as the treatment for DT differs from delirium due to other causes. Larger doses of benzodiazepines are often needed, and antipsychotics must be used with caution. Management ideally requires a high-dependency setting.
ACUTE BENZODIAZEPINE WITHDRAWAL
Assessment and identification
Symptoms of benzodiazepine withdrawal are shown in Table 2. Symptoms can occur within a wide timeframe from last benzodiazepine dose (due to variable half-lives), are non-specific, and can vary wildly from patient to patient. The risk of withdrawal symptoms increases with longer use, higher dosage, and concurrent alcohol or other drug dependence.
A full mental health assessment (CGO: Mental health assessment and initial interventions,) should be completed, and in addition the detailed alcohol history (Accordion content) can be of benefit.
Physical assessment should also be undertaken, with minimum 4 hourly physical observations conducted. Supportive management (fluids or antiemetic medication) may be required.
Table 2: Symptoms of benzodiazepine withdrawal
|
Physical
|
Psychological
|
|
Stiffness
Weakness
GI disturbance
Paraesthesia
Perspiration
Headache
Tremor
Loss of appetite
Nausea
Palpitations
Visual disturbance
Tinnitus
Seizures
|
Anxiety
Panic attacks
Insomnia
Nightmares
Depersonalisation
Decreased memory and concentration
Delusions and hallucinations
Depression
|
Management
The principle of management is to convert the patient to an equivalent dose of diazepam from whatever benzodiazepine they have been taking, and then gradually reduce this diazepam dose.
It is important to note that patients may be taking multiple types of benzodiazepine, and that without good rapport and encouragement they may under-report their dosing. Therefore good monitoring of withdrawal symptoms and physical health/observations should occur.
As with the management of acute alcohol withdrawal, early aeromed evacuation or transfer to a Role 3/4 facility is likely to be necessary due to the need for large quantities of diazepam. If this is not possible then early reach back from a mental health professional should be sought where possible.
The following stepwise discontinuation protocol, adapted from the BNF, can be used as a guide. The reduction schedule may be tailored to the individual patient as required:
1. Step 1: Transfer the patient onto an equivalent daily dose of diazepam, ideally taken as a single dose at night. See Table 3.
Table 3: Diazepam equivalent doses.
|
Approximate equivalent doses, diazepam 5 mg
|
|
Alprazolam
|
250 micrograms
|
|
Clobazam
|
10 mg
|
|
Clonazepam
|
250 micrograms
|
|
Flurazepam
|
7.5–15 mg
|
|
Chlordiazepoxide
|
12.5 mg
|
|
Loprazolam
|
0.5–1 mg
|
|
Lorazepam
|
500 micrograms
|
|
Lormetazepam
|
0.5–1 mg
|
|
Nitrazepam
|
5 mg
|
|
Oxazepam
|
10 mg
|
|
Temazepam
|
10 mg
|
- Step 2: Reduce diazepam dose in fortnightly steps of 2mg-2.5mg; if withdrawal symptoms occur, maintain this dose until symptoms improve.
- Step 3: Reduce the dose further, if necessary, in smaller fortnightly steps; it is better to reduce too slowly than too quickly
- Step 4: Stop completely; time needed for withdrawal can vary from about 4 weeks (or less) to a year or more.